Lifecore Biomedical, Inc. \De\ Q2 FY2021 Earnings Call

Lifecore Biomedical, Inc. \De\ (LFCR)

Earnings Call FY2021 Q2 Call date: 2021-01-06 Concluded

Quarter scorecard

Revenue

$23.79M

-83.3% YoY

Diluted EPS

$-0.40

Gross margin

45.3%

+34.4 pp YoY

Net income

-$11.62M

Canada $13.70M

-25.5%

Belgium $2.80M

-9.7%

Czechia $1.20M

All Other Countries $900,000

-55%

Switzerland $700,000

Ireland $400,000

-63.6%